‘Move slow to go fast’: Keeping pace with responsible AI with Michael Shaw
The rapid evolution of generative AI has led to increased adoption but also raises significant compliance challenges. ZS principal Michael Shaw discusses the importance of responsible and ethical AI adoption in the biopharma industry, particularly as it relates to compliance, risk management and improving patient outcomes.
Highlights include:
- The importance of developing a comprehensive framework for responsible AI, focusing on principles like fairness, safety, transparency and accountability
- Why effective AI governance requires cross-functional collaboration and continuous trade-off assessment
- How leveraging AI to enhance workflows can drive efficiency and effectiveness but must be implemented thoughtfully with the right controls in place
Listen now at the links below
default
